0001209191-23-031008.txt : 20230519 0001209191-23-031008.hdr.sgml : 20230519 20230519162718 ACCESSION NUMBER: 0001209191-23-031008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230517 FILED AS OF DATE: 20230519 DATE AS OF CHANGE: 20230519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COUGHLIN TIMOTHY CENTRAL INDEX KEY: 0001376043 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37378 FILM NUMBER: 23940534 MAIL ADDRESS: STREET 1: 339 NORTH GRANADOS AVE CITY: SOLANA BEACH STATE: CA ZIP: 92075 FORMER NAME: FORMER CONFORMED NAME: Coughlin Timothy P DATE OF NAME CHANGE: 20060919 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: aTYR PHARMA INC CENTRAL INDEX KEY: 0001339970 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203435077 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10240 SORRENTO VALLEY ROAD STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8587318389 MAIL ADDRESS: STREET 1: 10240 SORRENTO VALLEY ROAD STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-17 0 0001339970 aTYR PHARMA INC LIFE 0001376043 COUGHLIN TIMOTHY C/O ATYR PHARMA, INC. 10240 SORRENTO VALLEY ROAD, SUITE 300 SAN DIEGO CA 92121 1 0 0 0 0 Common Stock 2023-05-17 5 G 0 E 6000 0.00 D 0 D Common Stock 2023-05-17 5 G 0 E 6000 0.00 A 6000 I See Footnote Stock Option (right to buy) 2.52 2023-05-17 4 A 0 12000 0.00 A 2033-05-17 Common Stock 12000 12000 D These shares are owned by the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person and his spouse serve as co-trustees of the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person may be deemed to be the beneficial owner of the securities held by the Coughlin Family Trust u/a DTD 12/07/2006. The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 17, 2024 or (ii) the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. /s/ Nancy E. Denyes, as Attorney-in-Fact 2023-05-19